SCHEMBL23965397

SCHEMBL23965397

CC1(C)OB(c2nc(-c3ccc4ccccc4c3)nc(-c3ccc4ccccc4c3)n2)OC1(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.61
LIPG Q9Y5X9 5/20 0.61
CYP1A2 P05177 4/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HSD17B10 Q99714 3/20 0.39
KDM4E B2RXH2 3/20 0.39
TP53 P04637 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
KCNH2 Q12809 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965123 0.96 LPL (0.57) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL26272405 0.94 LIPG (0.59) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL23965291 0.92 LIPG (0.63) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL23965282 0.88 LPL (0.49) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL30125490 0.87 LIPG (0.78) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL19106579 0.87 LIPG (0.78) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL10263223 0.85 LPL (0.67) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL24475152 0.85 LIPG (0.81) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL23965040 0.85 LPL (0.46) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2
SCHEMBL19106578 0.84 LIPG (0.74) LPLLIPGCYP1A2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 LPL 2546/4885LIPG 3610/4885CYP1A2 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.